" class="no-js "lang="en-US"> Ayub Khattak - Pharmtech Focus
Tuesday, January 31, 2023
Ayub Khattak

Ayub Khattak

About Ayub Khattak

Ayub Khattak is co-founder and Chief Executive Officer of Cue Health, a health technology company whose mission is to enable personalized, proactive, and informed healthcare that empowers people to live their healthiest lives.

Ayub leads the Cue team of scientists, chemists, statisticians, engineers, and individuals experienced in FDA clearance of diagnostic products and more who are committed to creating a new standard of care in diagnostics, with the ability to bridge the physical to virtual care continuum and benefit everyone by keeping people healthy and productive.

Under Ayub’s leadership, the company developed the Cue Health Monitoring System that enables fast, frequent, lab-quality diagnostics by anyone, anywhere. Cue’s first commercially available product, the Cue COVID-19 Test Kit, provides highly accurate, lab-quality results, directly to connected mobile smart devices in about 20 minutes. The Cue COVID-19 Test was the first FDA-authorized molecular diagnostic test for at-home and over-the-counter use, without physician supervision or a prescription.

The idea for Cue was conceived in 2010 when Ayub and co-founder & Chief Product Officer Clint Sever recognized the problems with how the current health structure collects, communicates, and uses health data. They saw the opportunity to create a new model for care and started Cue to create tools that empower healthcare providers and consumers by increasing their access to actionable health data.

Ayub received a Bachelor of Science degree in mathematics from the University of California, Los Angeles, where he worked in the biochemistry laboratories. Ayub holds over 100 current and pending patents worldwide related to inventions covering various aspects of molecular diagnostics systems.

Related Story

Cue Health Appoints Suzanne Stone as New Chief Commercial Officer

September 28 2022

Cue Health Inc. (“Cue”) ( Nasdaq: HLTH), a healthcare technology company, today announced that it has appointed Suzanne […]

Cue Health Appoints David Tsay, MD, PhD, as Chief Medical Officer

September 9 2022

Cue Health Inc. (“Cue”) ( Nasdaq: HLTH), a healthcare technology company, today announced that it has appointed David […]

Cue Health Confirms COVID-19 Tests Can Detect Omicron Variant

November 29 2021

Cue Health (“Cue”) (Nasdaq: HLTH), a healthcare technology company, today announced it has completed an analysis […]

Helix and Cue Health Collaborate to Provide Individuals with Access to their COVID-19 Variant Sequencing Information

November 19 2021

Helix, a leading genomics company that provides nationwide viral surveillance of respiratory disease, and Cue […]

Cue Health Announces Completion of $235 Million Private Financing to Accelerate Growth

May 14 2021

Cue Health Inc. (“Cue Health” or “Cue”), a health technology company, today announced the closing […]